Metraipolis › archive › dc_04735c216b6d

Prolongation of prothrombin time-international normalized ratio by concomitant use of warfarin and combination therapy with lenvatinib and pembrolizumab in a… — Europe PMC PMID:42288908

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42288908
DOI
10.1186/s40780-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-10-31T12:09:54.512Z
SHA-256 of the archived text
c83a4ffad6b9007be44c9f5e0e37c102f345dd99a17717482b675f914eb3c09f
Stable URL of this page
https://metraipolis.com/documento/dc_04735c216b6d

How to cite

Prolongation of prothrombin time-international normalized ratio by concomitant use of warfarin and combination therapy with lenvatinib and pembrolizumab in a… — Europe PMC PMID:42288908 — Europe PMC (en), https://europepmc.org/article/MED/42288908 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04735c216b6d (Metraipolis archive dc_04735c216b6d, sha256 c83a4ffad6b9007be44c9f5e0e37c102f345dd99a17717482b675f914eb3c09f)
BibTeX
@misc{dc04735c216b6d,
  title = {Prolongation of prothrombin time-international normalized ratio by concomitant use of warfarin and combination therapy with lenvatinib and pembrolizumab in a… — Europe PMC PMID:42288908},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42288908},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04735c216b6d; sha256 c83a4ffad6b9007be44c9f5e0e37c102f345dd99a17717482b675f914eb3c09f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42288908. Agents can read the archived copy with the MCP tool read_document.